Financials
Financial year 2025
Dr. Liesbet Van Praet Reumatologie from Gent, company number BE0751581635, closed financial year 2025 with a result of € 136,126 after tax. For that financial year Dr. Liesbet Van Praet Reumatologie recorded a gross margin of € 179,725 and equity of € 86,077. Compared with financial year 2024, the result moved from € 130,433 to € 136,126. Profitable, and profit is growing. The buffer shrank hard: equity is 59 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 20, 2026.
€ 86,077
▼ 59% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 136,126
▲ 4% vs 2024
Profit after tax over the fiscal year.
€ 303,020
▲ € 236,051 vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 258,612 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 7,719
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,814
▼ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,470
▼ 10% vs 2024
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 151,222 | € 169,638 | € 179,725 | ▲ 6% |
| Profit after taxes | € 116,095 | € 130,433 | € 136,126 | ▲ 4% |
| Equity | € 208,563 | € 208,563 | € 86,077 | ▼ 59% |
| Total debts | € 162,340 | € 223,983 | € 301,993 | ▲ 35% |
| Cash | € 206,201 | € 66,969 | € 303,020 | ▲ € 236,051 |
| Land & buildings | € 2,037 | € 1,767 | € 1,497 | ▼ 15% |
| Retained profit | € 206,063 | € 206,063 | € 83,577 | ▼ 59% |
| Dividend | € 116,095 | € 130,433 | € 258,612 | ▲ 98% |
| Balance sheet total | € 370,903 | € 432,547 | € 388,070 | ▼ 10% |
Key figures of Dr. Liesbet Van Praet Reumatologie, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. Liesbet Van Praet Reumatologie?
What happened at Dr. Liesbet Van Praet Reumatologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 136,126 (▲ 4% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
- Liesbet Van Praet became a director. NBB
In short
From € 116,095 profit in 2023 to € 136,126 profit in 2025.
Paid € 110,124 in corporate taxes since 2023.
Best year ever: 2025, with € 136,126 profit.
Paid out € 505,140 in dividends to the owners in total.
Management
Behind Dr. Liesbet Van Praet Reumatologie is Liesbet Van Praet.
Directors
According to the 2025 annual accounts
Liesbet Van Praet
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Asselsstraat 8
9031 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0751.581.635
- VAT number
- BE 0751.581.635
- Registered office
- Asselsstraat 8, 9031 Gent
- Names & denominations
- Dr. Liesbet Van Praet Reumatologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 July 2020
- Peppol
- Active · Active since 25 Nov 2025
- Activities · NACE
Activiteiten van medisch specialisten
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Diverse administratieve activiteiten ten behoeve van kantoren
Overige gespecialiseerde wetenschappelijke en technische activiteiten